• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

J Microbiol . Efficiency of reverse genetics methods for rescuing severe acute respiratory syndrome coronavirus 2

tetano

Editor, Senior Moderator
J Microbiol


. 2025 Feb;63(2):e2411023.
doi: 10.71150/jm.2411023. Epub 2025 Feb 27. Efficiency of reverse genetics methods for rescuing severe acute respiratory syndrome coronavirus 2

Chang-Joo Park[SUP] 1 [/SUP], Taehun Kim[SUP] 2 [/SUP], Seung-Min Yoo[SUP] 1 [/SUP], Myung-Shin Lee[SUP] 1 [/SUP], Nam-Hyuk Cho[SUP] 2 [/SUP], Changhoon Park[SUP] 1 [/SUP]



Affiliations
Abstract

Bacteria-free reverse genetics techniques are crucial for the efficient generation of recombinant viruses, bypassing the need for labor-intensive bacterial cloning. These methods are particularly relevant for studying the pathogenesis of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the causative agent of COVID-19. This study compared the efficiency of three bacteria-free approaches-circular polymerase extension reaction (CPER) with and without nick sealing and infectious sub-genomic amplicons (ISA)-to bacterial artificial chromosome (BAC)-based technology for rescuing SARS-CoV-2. Significant differences in viral titers following transfection were observed between methods. CPER with nick sealing generated virus titers comparable to those of the BAC-based method and 10 times higher than those of the standard CPER. In contrast, ISA demonstrated extremely low efficiency, as cytopathic effects were detected only after two passages. All rescued viruses exhibited replication kinetics consistent with those of the original strain, with no significant deviation in replication capacity. Furthermore, the utility of CPER and ISA in genetically modifying SARS-CoV-2 was demonstrated by successfully inserting the gene encoding green fluorescent protein into the genome. Overall, this study underscores the potential of bacteria-free methods, such as CPER and ISA, in advancing SARS-CoV-2 research while highlighting their significant differences in efficiency.

Keywords: SARS-CoV-2; circular polymerase extension reaction; infectious clone; infectious sub-genomic amplicons; reverse genetics.

 
Back
Top Bottom